Medical Device Company CVRx Adopts Configurable ARC(R) Core For Implantable Blood Pressure Reduction Device.ST. ALBANS, England -- ARC International (LSE LSE - Language Sensitive Editor :ARK) today announced that CVRx([R]), Inc. has chosen a member of the configurable ARC([R]) 600 core family to drive its Rheos([TM]) Baroreflex Hypertension Therapy([TM]) System. CVRx chose a configurable ARC core because of its very small size, ability to operate using extremely low power, and long-term reliability - all key criteria for "deeply embedded" organic applications. This news release complements ARC's announcement of the adoption of its configurable solutions by 11 companies in North America. See companion announcement dated July 11, 2007 for more details. Hypertension (high blood pressure) is an excessive force of blood against arterial walls. It is a leading cause of heart and kidney disease Kidney Disease Definition Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease. , stroke, and premature death. According to the American Heart Association American Heart Association (AHA), n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities. , close to 70 million people in the United States suffer from high blood pressure. Approximately 25 percent cannot control the disease despite the use of multiple medications. The Rheos System from CVRx reduces blood pressure by using the human body's natural blood pressure regulation system (the baroreflex). The Rheos System electrically stimulates the baroreflex, which sends signals to the brain suggesting a blood pressure increase. Then, the brain acts to lower blood pressure by sending signals to various parts of the body, including the blood vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. , heart and kidneys. The Rheos System includes a small pulse generator Pulse generator An electronic circuit capable of producing a waveform that rises abruptly, maintains a relatively flat top for an extremely short interval, and then rapidly falls to zero. that is implanted under the collar bone, two thin leads that are wrapped around the left and right carotid arteries Carotid arteries The four principal arteries of the neck and head. There are two common carotid arteries, each of which divides into the two main branches (internal and external). Mentioned in: Endarterectomy , and a programmer system. "The Rheos System holds hope for patients with drug-resistant hypertension," said Nadim Yared, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CVRx. "By adopting a configurable ARC processor our development teams can ensure the implantable, battery operated Rheos System meets important criteria necessary for implantable medical devices." Andy Jaros, vice president of worldwide field operations for ARC, said, "For years ARC's configurable processors have been broadly used in a wide range of medical products. From pacemakers to hearing aids Hearing Aids Definition A hearing aid is a device that can amplify sound waves in order to help a deaf or hard-of-hearing person hear sounds more clearly. , ARC's low power configurable solutions are being adopted to create innovative next-generation medical technologies. Products such as the Rheos System from one of ARC's newest customers could have a beneficial impact on the health and life expectancy of millions of individuals worldwide." About CVRx, Inc. CVRx was founded in 2001 and is headquartered in Minneapolis. It is a private company and its senior management and technical teams have many years of experience commercializing implantable medical devices. For more information visit www.cvrx.com. About ARC International plc ARC International is the world leader in configurable media subsystems and CPU/DSP processors. Used by over 140 companies worldwide, ARC's configurable solutions enable the creation of highly differentiated system-on-chips (SoCs) that ship in hundreds of millions of devices annually. ARC's patented subsystems and cores are smaller, consume less power, and are less expensive to manufacture than competing products. ARC International maintains a worldwide presence with corporate and research and development offices in California and St. Albans, UK. For more information visit www.ARC.com. ARC International is listed on the London Stock Exchange London Stock Exchange London marketplace for securities. It was formed in 1773 by a group of stockbrokers who had been doing business informally in local coffeehouses. as ARC International plc (LSE:ARK). ARC and the ARC logo are trademarks or registered trademarks of ARC International. All other brands or product names contained herein are the property of their respective owners. This press release may contain certain "forward-looking statements" that involve risks and uncertainties, including the development, implementation, and release of features described herein. These are at the sole discretion of ARC International. For other factors that could cause actual results to differ, visit the company's Website as well as the listing particulars filed with the United Kingdom Listing Authority and the Registrar of Companies The introduction to this article provides insufficient context for those unfamiliar with the subject matter. Please help [ improve the introduction] to meet Wikipedia's layout standards. You can discuss the issue on the talk page. in England and Wales England and Wales are both constituent countries of the United Kingdom, that together share a single legal system: English law. Legislatively, England and Wales are treated as a single unit (see State (law)) for the conflict of laws. . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion